Fingerprint
Dive into the research topics of 'A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically